Cibinqo, used for atopic dermatitis, has a price influenced by multiple factors. High R&D costs are a major contributor as developing this JAK inhibitor involved extensive research.
Patent protection gives Pfizer, the manufacturer, market exclusivity, allowing for higher pricing. Production costs, including specialized manufacturing processes and quality control, also play a part. Market demand and competition matter too. In regions with more patients needing treatment and fewer alternative drugs, prices may be set higher. Additionally, healthcare policies and insurance coverage in different countries can significantly impact the final price patients pay.

